Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M101Revenue (TTM) $M49.9Net Margin (%)-175.5Altman Z-Score-24.0
Enterprise Value $M17.2EPS (TTM) $-0.5Operating Margin %-170.6Piotroski F-Score1
P/E(ttm)--Beneish M-Score-2.8Pre-tax Margin (%)-178.3Higher ROA y-yN
Price/Book1.710-y EBITDA Growth Rate %-53.9Quick Ratio2.4Cash flow > EarningsN
Price/Sales1.85-y EBITDA Growth Rate %-30.7Current Ratio2.5Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-93.6Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-480.8Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M283ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with CTIC

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

CTIC is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CTIC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BIANCO JAMES APresident and CEO 2016-06-24Sell10,000$0.37-2.7view
BIANCO JAMES APresident and CEO 2016-05-27Sell10,000$0.45-20view
BIANCO JAMES APresident and CEO 2016-04-29Sell10,000$0.52-30.77view
BIANCO JAMES APresident and CEO 2016-03-28Sell10,000$0.49-26.53view
BIANCO JAMES APresident and CEO 2016-03-21Sell318,169$0.55-34.55view
Plunkett MatthewEVP, Chief Business Officer 2016-03-04Sell10,000$0.59-38.98view
BIANCO JAMES APresident and CEO 2016-02-26Sell10,000$0.63-42.86view
SINGER JACK WEVP, Chief Scientific Officer 2016-02-26Sell15,000$0.63-42.86view
BIANCO JAMES APresident and CEO 2016-02-16Sell100,000$0.42-14.29view
Plunkett MatthewEVP, Chief Business Officer 2016-02-04Sell10,000$1.15-68.7view

Press Releases about CTIC :

Quarterly/Annual Reports about CTIC:

News about CTIC:

Articles On GuruFocus.com
Monday Morning Pre-Market Insights: Celldex Therapeutics, Celladon Corp, CTI BioPharma Corp, TG Ther Jun 01 2015 
Weekly CEO Sells Highlight: Groupon Inc., Cell Therapeutics Inc., Standard Pacific Corp and Dollar G Mar 24 2014 
These 4 Biotech Stocks Are a Buy Now Feb 08 2012 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 50,000 Shares Feb 25 2011 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 50,000 Shares Jan 28 2011 
Weekly CEO Sells Highlight: CTIC, DDR, UNM, BRCM, TC Jan 09 2011 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 250,000 Shares Jan 03 2011 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 200,000 Shares Dec 17 2010 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 150,000 Shares Dec 10 2010 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 100,000 Shares Nov 05 2010 

More From Other Websites
CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Jun 30 2016
ETF’s with exposure to CTI BioPharma Corp. : June 27, 2016 Jun 27 2016
Surging Earnings Estimates Signal Good News for CTI BioPharma (CTIC) Jun 10 2016
Should CTI BioPharma (CTIC) Be On Your Radar Now? Jun 08 2016
Long-Term Follow Up Data For Pacritinib Presented At 2016 ASCO Annual Meeting Jun 07 2016
ETF’s with exposure to CTI BioPharma Corp. : June 3, 2016 Jun 03 2016
CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... May 31 2016
ETF’s with exposure to CTI BioPharma Corp. : May 20, 2016 May 20 2016
CTI BioPharma Corp. :CTIC-US: Earnings Analysis: Q1, 2016 By the Numbers May 19 2016
CTI BIOPHARMA CORP Financials May 19 2016
CTI BioPharma Announces Presentations At The American Society Of Clinical Oncology Annual Meeting May 19 2016
CTI BioPharma posts 1Q profit May 10 2016
CTI BioPharma posts 1Q profit May 10 2016
CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... May 10 2016
CTI BioPharma Reports First Quarter 2016 Financial Results May 10 2016
BrainStorm Cell Therapeutics Reports First Quarter 2016 Financial Results And Provides Corporate... May 10 2016
CTI BIOPHARMA CORP Files SEC form 8-K, Change in Directors or Principal Officers, Submission of... Apr 29 2016
CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Apr 28 2016
Preclinical Data Presented At AACR Indicate Pacritinib's Potential To Eradicate Therapy-Resistant... Apr 20 2016
CTI BIOPHARMA CORP Files SEC form 8-K, Other Events Apr 18 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)